Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromatherapy for Chemotherapy-Induced Nausea and Vomiting
NCT05319860Phase 2Completed
- Sponsor
- University of Miami
- Start
- Aug 2022
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Miami. Primary endpoints: Acute and Delayed Chemotherapy-Induced Nausea and Acute and Delayed Chemotherapy-Induced Vomiting. Started Aug 2022; status: completed.
02
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05319860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05319860.